Mapping the Debate / At What Cost?
A new era of prescription drugs has seen record numbers of FDA approved drugs enter the market, helping millions fight disease. At the same time, drug prices are soaring, and debates have resonated from Washington and beyond on how to transform health care and reduce spending. How can the health care industry work to make prescription drugs more affordable?
The Atlantic convened top health policy thinkers and practitioners to explore how to foster drug innovation while controlling cost with new approaches like value-based programs on the horizon.
- David Certner, Legislative Counsel and Policy Director for Government Affairs, AARP
- Matt Eyles, Executive Vice President of Policy and Regulatory Affairs, America’s Health Insurance Plans
- Lori Reilly, Executive Vice President, Policy and Research, PhRMA
- With Matt Thompson, The Atlantic